BiotechTube
Home/ImmuneSensor Therapeutics/Betty Lawrence
BL

Betty Lawrence

VP, Toxicology and Regulatory

ImmuneSensor Therapeutics

Therapeutic Areas

Autoimmune DiseasesInflammatory DiseasesOncology

ImmuneSensor Therapeutics Pipeline

DrugIndicationPhase
IMSA101Oncology (STING Agonist)Phase 1
IMSB301Inflammatory/Autoimmune Diseases (cGAS Inhibitor)Phase 1

Leadership Team at ImmuneSensor Therapeutics

TW
Thomas W. Dubensky, Jr., Ph.D.
President and Chief Executive Officer
JL
Jet Li
Board Chairman and Co-Founder
L'
Lijun 'Josh' Sun, Ph.D.
VP, Research & Development
TM
Teresa Mooneyham
VP, Clinical Operations & Head of Project Management
View full ImmuneSensor Therapeutics profile